Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Prostate cancer screening

Decline in Prostate Cancer Screening Raises Concerns and Sparks Debate

Learn about the significant decline in prostate cancer screening rates following the 2012 recommendation against routine testing. Discover the varied reactions within the medical community and the impact on prostate cancer diagnoses. Find out how recent studies have shed light on the consequences of decreased PSA testing and the potential benefits and risks associated with the shift away from routine screenings.

Limitations of PSA Prostate Cancer Test Revealed in Recent Study

A recent study has revealed the limitations of the commonly used PSA prostate cancer test, which may fail to detect some aggressive forms of the disease. This raises concerns about the reliability of the test and the need for more accurate screening methods for prostate cancer. Experts emphasize the importance of discussing the limitations of the PSA test with healthcare providers and the need for continued research to develop improved screening tools.